Neuronetics, Inc.
STIM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001227636
In the last 90 days, Neuronetics, Inc. insiders filed 2 open-market purchases and 0 sales; 86 institutions reported holding it in 13F filings for Q2 2026, worth $48.4M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Neuronetics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 102
- +58 vs. Q4 2024
- Shares held
- 17.2M
- +9.63M (+127.5%) vs. Q4 2024
- Total value
- $63.2M
- +$51.0M (+417.8%) vs. Q4 2024
- New holders
- 62
- 15 more added
- Sold out
- 4
- 12 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting STIM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 86 | $48.4M |
| Q1 2026 | 99 | $60.4M |
| Q4 2025 | 95 | $58.3M |
| Q3 2025 | 99 | $57.8M |
| Q2 2025 | 90 | $63.1M |
| Q1 2025 | 102 | $63.2M |
| Q4 2024 | 45 | $12.2M |
| Q3 2024 | 48 | $8.05M |
| Q2 2024 | 67 | $31.5M |
| Q1 2024 | 66 | $84.2M |
| Q4 2023 | 66 | $46.2M |
| Q3 2023 | 56 | $23.4M |
| Q2 2023 | 69 | $38.6M |
| Q1 2023 | 74 | $53.6M |
| Q4 2022 | 82 | $120.4M |
| Q3 2022 | 76 | $54.4M |
| Q2 2022 | 77 | $56.4M |
| Q1 2022 | 83 | $59.9M |
| Q4 2021 | 80 | $89.0M |
| Q3 2021 | 97 | $139.9M |
| Q2 2021 | 105 | $373.7M |
| Q1 2021 | 83 | $256.4M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Neuronetics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Balyasny Asset Management LLC | 1,417,051 | $5.21M | 0.01% | −64,720−4.4% | Reduced |
| Vanguard Group Inc | 2,306,070 | $8.49M | 0.00% | +1,024,680+80.0% | Added |
| Accurate Wealth Management, LLC | 0 | $0 | 0.00% | −78,927−100.0% | Sold out |
| Wealthedge Investment Advisors, LLC | 0 | $0 | 0.00% | −35,199−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −30,689−100.0% | Sold out |
| Quinn Opportunity Partners LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Criterion Capital Advisors, LLC | – | – | – | – | Not filed |